BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37594337)

  • 1. Serious infections and tuberculosis in psoriasis patients receiving systemic therapy in Korea: a nationwide population-based cohort study.
    Cho YA; Ahn J; Hong JY; Won S; Kim SM; Sung JY; Kim CY; Yu DA; Lee YW; Choe YB
    Eur J Dermatol; 2023 Jun; 33(3):287-295. PubMed ID: 37594337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of malignancy in patients with psoriasis according to treatment modalities in Korea: a nationwide cohort study.
    Hong JY; Ahn J; Won S; Kim SM; Cho YA; Kim CY; Sung JY; Yu DA; Lee YW; Choe YB
    Sci Rep; 2022 Nov; 12(1):20690. PubMed ID: 36450739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of serious infection and infection mortality in patients with psoriasis: A nationwide cohort study using the Taiwan National Health Insurance claims database.
    Chen TC; Wang TC; Yiu ZZN; Lee MS; Chen LC; Chan KA; Griffiths CEM; Ashcroft DM;
    J Eur Acad Dermatol Venereol; 2024 Jan; 38(1):136-144. PubMed ID: 37611288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential impact of systemic anti-inflammatory therapies in psoriasis on major adverse cardiovascular events: a Korean nationwide cohort study.
    Hong JR; Jeong H; Kim H; Yang HS; Hong JY; Kim SM; Cho YA; Lee YW; Choe YB; Ahn KJ
    Sci Rep; 2021 Apr; 11(1):8588. PubMed ID: 33883587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased dental comorbidities in patients with psoriasis: a nationwide population-based cohort study in Korea.
    Kwak EJ; Choi YJ; Kim HN; Kim KE; Jeon J; Baek YS
    Clin Exp Dermatol; 2023 Nov; 48(12):1347-1353. PubMed ID: 37624999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between different systemic therapies and the risk of tuberculosis in psoriasis patients: A population-based study.
    Ting SW; Ting SY; Lin YS; Lin MS; Kuo G
    Int J Clin Pract; 2021 Dec; 75(12):e15006. PubMed ID: 34773345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serious infection risk in children with psoriasis on systemic treatment: A propensity score-matched population-based study.
    Schneeweiss MC; Huang JT; Wyss R; Schneeweiss S; Merola JF
    J Am Acad Dermatol; 2020 Jun; 82(6):1337-1345. PubMed ID: 32142748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nationwide population-based cohort study of the incidence of severe and rare infections among adults with psoriasis in Denmark.
    Loft N; Skov L; Richardson C; Trivedi V; Alarcon I; Egeberg A
    Br J Dermatol; 2022 Sep; 187(3):353-363. PubMed ID: 35383888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between traditional systemic antipsoriatic drugs and tuberculosis risk in patients with psoriasis with or without psoriatic arthritis: results of a nationwide cohort study from Taiwan.
    Chen YJ; Wu CY; Shen JL; Chen TT; Chang YT
    J Am Acad Dermatol; 2013 Jul; 69(1):25-33. PubMed ID: 23375515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serious infections among a large cohort of subjects with systemically treated psoriasis.
    Dobry AS; Quesenberry CP; Ray GT; Geier JL; Asgari MM
    J Am Acad Dermatol; 2017 Nov; 77(5):838-844. PubMed ID: 28917384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of malignancy in patients with psoriasis: a 15-year nationwide population-based prospective cohort study in Korea.
    Lee JW; Jung KJ; Kim TG; Lee M; Oh J; Jee SH; Lee MG
    J Eur Acad Dermatol Venereol; 2019 Dec; 33(12):2296-2304. PubMed ID: 31287593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Biologics Use and Risk of Serious Infection in Patients With Psoriasis.
    Penso L; Dray-Spira R; Weill A; Pina Vegas L; Zureik M; Sbidian E
    JAMA Dermatol; 2021 Sep; 157(9):1056-1065. PubMed ID: 34287624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer risk in 892 089 patients with psoriasis in Korea: A nationwide population-based cohort study.
    Lee JH; Kim HJ; Han KD; Kim HN; Park YM; Lee JY; Park YG; Lee YB
    J Dermatol; 2019 Feb; 46(2):95-102. PubMed ID: 30443930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of Serious Infection in Patients with Psoriasis Receiving Biologic Therapies: A Prospective Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR).
    Yiu ZZN; Smith CH; Ashcroft DM; Lunt M; Walton S; Murphy R; Reynolds NJ; Ormerod AD; Griffiths CEM; Warren RB;
    J Invest Dermatol; 2018 Mar; 138(3):534-541. PubMed ID: 29054603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the U.K. and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR).
    Yiu ZZN; Ashcroft DM; Evans I; McElhone K; Lunt M; Smith CH; Walton S; Murphy R; Reynolds NJ; Ormerod AD; Griffiths CEM; Warren RB;
    Br J Dermatol; 2019 Feb; 180(2):329-337. PubMed ID: 30070708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased risk of suicidality in patients with psoriasis: A Nationwide cohort study in Korea.
    Kim SM; Ahn J; Cho YA; Sung JY; Kim CY; Yu DA; Lee YW; Won S; Choe YB
    J Eur Acad Dermatol Venereol; 2023 Jan; 37(1):75-84. PubMed ID: 36028994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of biologic agents on body weight and obesity-related disorders in patients with psoriasis: A nationwide population-based cohort study.
    Kim H; Hong JY; Cheong S; Kang JH
    Obes Res Clin Pract; 2023; 17(3):210-217. PubMed ID: 37211465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Risk of Major Adverse Cardiovascular Events With Biologic Therapy in Patients With Psoriasis.
    Bissonnette R; Kerdel F; Naldi L; Papp K; Galindo C; Langholff W; Tang KL; Szapary P; Fakharzadeh S; Srivastava B; Goyal K; Gottlieb AB
    J Drugs Dermatol; 2017 Oct; 16(10):1002-1013. PubMed ID: 29036254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The incidence rates and risk factors of Parkinson disease in patients with psoriasis: A nationwide population-based cohort study.
    Lee JH; Han K; Gee HY
    J Am Acad Dermatol; 2020 Dec; 83(6):1688-1695. PubMed ID: 31302182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of incident cataract in patients with psoriasis: A population-based cohort study.
    Cheng CY
    J Dermatol; 2022 Mar; 49(3):359-367. PubMed ID: 34862667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.